Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$883.2 - $1071.19 $48,576 - $58,915
55 Added 18.84%
347 $364,000
Q1 2024

May 10, 2024

SELL
$902.69 - $993.35 $40,621 - $44,700
-45 Reduced 13.35%
292 $281,000
Q4 2023

Jan 31, 2024

BUY
$775.18 - $881.7 $7,751 - $8,817
10 Added 3.06%
337 $295,000
Q3 2023

Nov 01, 2023

BUY
$692.45 - $844.37 $47,779 - $58,261
69 Added 26.74%
327 $269,000
Q1 2023

May 08, 2023

BUY
$680.49 - $826.97 $175,566 - $213,358
258 New
258 $211,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Beaumont Financial Advisors, LLC Portfolio

Follow Beaumont Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Advisors, LLC with notifications on news.